Interim Guidance for Antigen Testing for SARS-CoV-2

Authors: CDC

Summary of Recent Changes

Updates as of May 13, 2021

  • Updated guidance based on new published studies on antigen test performance.
  • Clarification about which NAATs should be used for confirmatory testing.
  • Considerations for people who have had previous SARS-CoV-2 infections and those who have been fully vaccinated.
  • Two new antigen testing algorithms, one for congregate living settings, and one for community settings.
  • Updates to testing suggestions for fully vaccinated, asymptomatic people.
    View Previous Updates

Key Points

  • This interim guidance is intended for healthcare providers who order antigen tests, receive antigen test results, or perform point-of-care testing, as well as for laboratory professionals who perform antigen testing in a laboratory setting or at the point of care and report those results.
  • The purpose of this interim technical guidance is to support effective clinical and public health use of antigen tests for different testing situations.
  • This guidance applies to all clinical and consumer uses of antigen tests and is not specific to any particular age group.
  • This guidance incorporates considerations for fully vaccinated people and should be used in conjunction with CDC’s Interim Public Health Recommendations for Fully Vaccinated People.

For More Information:

Leave a Reply

Your email address will not be published.